Lesogaberan hydrochloride

(Synonyms: AZD-3355 hydrochloride)
目录号: PL01097 纯度: ≥98%
Lesogaberan (AZD-3355) hydrochloride 是一种有效的选择性 GABAB 受体激动剂,对人重组 GABAB 受体的 EC50 为 8.6 nM。通过脑膜中 [3H]GABA 结合位移测量,Lesogaberan hydrochloride 对大鼠 GABAB 和 GABAA 受体的亲和力 (Kis):分别为 5.1 nM 和 1.4 μM。Lesogaberan hydrochloride 通过外周作用模式抑制短暂的食管下括约肌松弛。
商品编号 规格 价格 会员价 是否有货 数量
PL01097-5mg 5mg ¥6429.00 请登录
PL01097-10mg 10mg ¥10929.00 请登录
PL01097-25mg 25mg ¥21698.00 请登录
PL01097-50mg 50mg 询价 询价
PL01097-100mg 100mg 询价 询价
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Lesogaberan hydrochloride
英文名称
Lesogaberan hydrochloride
包装储存
4°C, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
详情描述
Lesogaberan (AZD-3355) hydrochloride 是一种有效的选择性 GABAB 受体激动剂,对人重组 GABAB 受体的 EC50 为 8.6 nM。通过脑膜中 [3H]GABA 结合位移测量,Lesogaberan hydrochloride 对大鼠 GABAB 和 GABAA 受体的亲和力 (Kis):分别为 5.1 nM 和 1.4 μM。Lesogaberan hydrochloride 通过外周作用模式抑制短暂的食管下括约肌松弛。
产品详情
Lesogaberan (AZD-3355) hydrochloride 是一种有效的选择性 GABAB 受体激动剂,对人重组 GABAB 受体的 EC50 为 8.6 nM。通过脑膜中 [3H]GABA 结合位移测量,Lesogaberan hydrochloride 对大鼠 GABAB 和 GABAA 受体的亲和力 (Kis):分别为 5.1 nM 和 1.4 μM。Lesogaberan hydrochloride 通过外周作用模式抑制短暂的食管下括约肌松弛。
生物活性
Lesogaberan (AZD-3355) hydrochloride is a potent and selective GABA B receptor agonist with an EC 50 of 8.6 nM for human recombinant GABA B receptor. The affinity (K i s) of Lesogaberan hydrochloride for rat GABA B and GABA A receptors, as measured by displacement of [H]GABA binding in brain membranes: 5.1 nM and 1.4 μM, respectively. Lesogaberan hydrochloride inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action.
性状
Viscous liquid
IC50 & Target[1][2]
Ki: 5.1±1.2 nM (rat GABAB), 1.4±0.3 μM (rat GABAA)
EC50: 8.6±0.77 nM (human GABAB receptor)
体外研究(In Vitro)
Lesogaberan hydrochloride (3-30 nM) enhances human islet cell proliferation in vitro. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Proliferation AssayCell Line:
体内研究(In Vivo)
Lesogaberan hydrochloride potently stimulates recombinant human GABA B receptors and inhibits transient lower esophageal sphincter relaxation (TLESR) in dogs, with a biphasic dose-response curve.
Oral Lesogaberan (0.08?mg/mL; 48 hours) hydrochloride protects human islet β-cells from apoptosis in islet grafts in mice.
Lesogaberan (7 μmol/kg) hydrochloride shows high oral availability (88% in the dog and 100% in the rat) and relatively low systemic clearance in female SpragueDawley rats. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
ClinicalTrial
参考文献
[1]. Lehmann A, et al. (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action. J Pharmacol Exp Ther. 2009 Nov;331(2):504-12.
[2]. Tian J, et al. Repurposing Lesogaberan to Promote Human Islet Cell Survival and β-Cell Replication. J Diabetes Res. 2017;2017:6403539.
溶解度数据
In Vitro: DMSO : 240 mg/mL (1351.81 mM; Need ultrasonic)H2O : 100 mg/mL (563.25 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)
[1]. Lehmann A, et al. (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action. J Pharmacol Exp Ther. 2009 Nov;331(2):504-12.
[2]. Tian J, et al. Repurposing Lesogaberan to Promote Human Islet Cell Survival and β-Cell Replication. J Diabetes Res. 2017;2017:6403539.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2